Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      SpringWorks Therapeutics to Present Progress Across the Company’s Targeted Oncology Portfolio at Virtual R&D Day
      Biotech

      SpringWorks Therapeutics to Present Progress Across the Company’s Targeted Oncology Portfolio at Virtual R&D Day

      July 1, 2022
      Celldex Announces Two New Appointments to its Board of Directors
      Biotech

      Celldex Announces Two New Appointments to its Board of Directors

      July 1, 2022
      Agios Presents New Clinical Data Supporting the Benefits of PYRUKYND® (mitapivat) Treatment in Adults with PK Deficiency at European Hematology Association Annual Congress
      Biotech

      Agios Presents New Clinical Data Supporting the Benefits of PYRUKYND® (mitapivat) Treatment in Adults with PK Deficiency at European Hematology Association Annual Congress

      July 1, 2022
      Day One Announces Pricing of Upsized Public Offering of Common Stock
      Biotech

      Day One Announces Pricing of Upsized Public Offering of Common Stock

      July 1, 2022
      BMTC GROUP INC. ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED APRIL 30th, 2022.
      Biotech

      BMTC GROUP INC. ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED APRIL 30th, 2022.

      July 1, 2022
      Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability
      Biotech

      Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability

      July 1, 2022
      Hoth Therapeutics Granted 180 Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
      Biotech

      Hoth Therapeutics Granted 180 Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

      July 1, 2022
      NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer
      Biotech

      NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer

      July 1, 2022
      100th ReWalk Exoskeleton Supplied in Germany
      Biotech

      100th ReWalk Exoskeleton Supplied in Germany

      June 23, 2022
      Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
      Biotech

      Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial

      June 23, 2022
      « 1 … 127 128 129 130 131 132 »

       

      LATEST NEWS

      • Investing News Reddit’s Financial Surge in Q4 2025
      • Investing News AWS Q4 2025 Earnings Review
      • Investing News Roblox Stock Surges on Earnings Beat
      • Investing News Industrial Gas Giant’s Stock Plummets
      • Investing News Amazon’s Market Challenges Explained

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026